EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems

Dragana Nikitovic iD, Ekaterina Kukovyakina, Aikaterini Berdiaki, Alexandros Tzanakakis, Anna Luss, Elizaveta Vlaskina iD, Anne Yagolovich, Aristides Tsatsakis iD, Andrey Kuskov iD

Cancers · 08.11.2024 · 16 (22) · 3768

DOI: 10.3390/cancers16223768 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 08.11.2024. Verfasst von Dragana Nikitovic und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology-Embryology, Medical School, University of Crete, 71003 Heraklion, Greece. Die Arbeit wurde bisher 81-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy remains the primary therapeutic approach in treating cancer. The tumor microenvironment (TME) is the complex network surrounding tumor cells, comprising various cell types, such as immune cells, fibroblasts, and endothelial cells, as well as ECM components, blood vessels, and signaling molecules. The often stiff and dense network of the TME interacts dynamically with tumor cells, influencing cancer growth, immune response, metastasis, and resistance to therapy. The effectiveness of the treatment of solid tumors is frequently reduced due to the poor penetration of the drug, which leads to attaining concentrations below the therapeutic levels at the site. Cell-penetrating peptides (CPPs) present a promising approach that improves the internalization of therapeutic agents. CPPs, which are short amino acid sequences, exhibit a high ability to pass cell membranes, enabling them to deliver drugs efficiently with minimal toxicity. Specifically, the iRGD peptide, a member of CPPs, is notable for its capacity to deeply penetrate tumor tissues by binding simultaneously integrins ανβ3/ανβ5 and neuropilin receptors. Indeed, ανβ3/ανβ5 integrins are characteristically expressed by tumor cells, which allows the iRGD peptide to home onto tumor cells. Notably, the respective dual-receptor targeting mechanism considerably increases the permeability of blood vessels in tumors, enabling an efficient delivery of co-administered drugs or nanoparticles into the tumor mass. Therefore, the iRGD peptide facilitates deeper drug penetration and improves the efficacy of co-administered therapies. Distinctively, we will focus on the iRGD mechanism of action, drug delivery systems and their application, and deliberate future perspectives in developing iRGD-conjugated therapeutics. In summary, this review discusses the potential of iRGD in overcoming barriers to drug delivery in cancer to maximize treatment efficiency while minimizing side effects.

Schlagwörter

Stichwörter der Autor:innen

cancer therapycell-penetrating peptides (CPPs)iRGDnanocarrierstumor microenvironment

Autor:innen und Institutionen

  • Department of Histology-Embryology, Medical School, University of Crete, 71003 Heraklion, Greece.
  • Department of Technology of Chemical Pharmaceutical and Cosmetic Products, D. Mendeleev University of Chemical Technology of Russia, 125047 Moscow, Russia.
  • School of Electrical and Computer Engineering, National Technical University of Athens, 15780 Athens, Greece.
  • Faculty of Biology, Lomonosov Moscow State University, 119234 Moscow, Russia.
  • Forensic Medicine Department, Medical School, University of Crete, 71003 Heraklion, Greece.

ORCID-Profile: Dragana Nikitovic, Elizaveta Vlaskina, Aristides Tsatsakis, Andrey Kuskov

Förderung

  • Russian Science Foundation

Zitieren

APA

Nikitovic, D., Kukovyakina, E., Berdiaki, A., Tzanakakis, A., Luss, A., Vlaskina, E., Yagolovich, A., Tsatsakis, A., & Kuskov, A. (2024). Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems. Cancers, 16(22), 3768. https://doi.org/10.3390/cancers16223768

Vancouver

Nikitovic D, Kukovyakina E, Berdiaki A, Tzanakakis A, Luss A, Vlaskina E, et al. Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems. Cancers. 2024;16(22):3768. doi:10.3390/cancers16223768

BibTeX
@article{Nikitovic2024,
  author = {Nikitovic, Dragana and Kukovyakina, Ekaterina and Berdiaki, Aikaterini and Tzanakakis, Alexandros and Luss, Anna and Vlaskina, Elizaveta and Yagolovich, Anne and Tsatsakis, Aristides and Kuskov, Andrey},
  title = {Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {22},
  pages = {3768},
  doi = {10.3390/cancers16223768}
}
Kostenlos starten →